NGEN
NervGen Pharma Corp. Common stock
NGEN
Closed
$1.75
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
The company is headquartered in Vancouver, British Columbia. The company went IPO on 2019-03-13.
Key stats
Open
$2.05
Volume
1.13M
Market cap
$162.98M
Prev. close
$1.93
Impl / hst vl
-
Open interest
$0.00
$1.72
Day’s Range
$2.06
$1.70
52W Range
$5.97
Valuation
22
Valuation score
Overvalued
P/E
-
P/S
-
P/B
-
Current ratio
0.79
Debt / Equity
-
ROE
-
Gross margin
-
Income growth
-54.35%
FCF growth
45.10
Analysts estimates
Consensus rating
Buy
The average rating from top 6 analysts indicates that stock is expected to perform in line with the market
Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$5.70
The top 6 analysts forecasts that 12-month price may increase by 225.67%, with a low of $3.71 and a high of $7.49
$3.71
Low
$5.70
Avg
$7.49
High
Current price
Earnings
Q3 ‘25 revenue
$0.00
Q3 ‘25 net income
-$2.94M
Revenue
Net income
Previous EPS
-Estimate EPS
-$0.04
Actual EPS
Estimate EPS
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply